Rhythm Pharmaceuticals (RYTM) Deferred Taxes (2021)

Rhythm Pharmaceuticals' (RYTM) quarterly Deferred Taxes came in at -$9.0 million in Q3 2021, down 79.11% on a QoQ basis from -$5.0 million in Q2 2021.

Rhythm Pharmaceuticals (RYTM) Deferred Taxes (2021) Analysis & Trends

Rhythm Pharmaceuticals (RYTM) has 1 years of Deferred Taxes data on file, last reported at -$9.0 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -188,883.60
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -65.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 96.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Rhythm Pharmaceuticals 6.98 Bn 6.64 Bn 52.96 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2021 -9.00 Mn
Jun 30, 2021 -5.02 Mn
Mar 31, 2021 22.01 Mn